Skip to main content
AMIX
NASDAQ Industrial Applications And Services

Autonomix Medical Receives Nasdaq Delisting Warning for Sub-$1.00 Bid Price

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
9
Price
$0.463
Mkt Cap
$3.199M
52W Low
$0.461
52W High
$3.325
Market data snapshot near publication time

summarizeSummary

Autonomix Medical, Inc. received a deficiency letter from Nasdaq due to its common stock trading below the minimum $1.00 bid price for 30 consecutive business days. This is a critical event as failure to regain compliance within the 180-day period could lead to delisting from the Nasdaq Capital Market, significantly impacting the company's liquidity and investor confidence. The company is currently trading near its 52-week low, making the challenge to meet the $1.00 threshold more difficult. A reverse stock split is a common, though often dilutive, measure companies take in such situations to boost share price.


check_boxKey Events

  • Nasdaq Deficiency Notice Received

    On January 14, 2026, Autonomix Medical, Inc. received a letter from Nasdaq notifying it of non-compliance with the minimum $1.00 bid price requirement (Nasdaq Listing Rule 5550(a)(2)).

  • 180-Day Compliance Period

    The company has an initial period of 180 calendar days, until July 13, 2026, to regain compliance. To do so, its common stock must close at $1.00 or more for a minimum of 10 consecutive business days.

  • Potential Delisting Risk

    Failure to regain compliance could result in the delisting of the company's common stock from the Nasdaq Capital Market, potentially moving to an over-the-counter market.

  • Consideration of Reverse Stock Split

    The company intends to monitor its stock price and may consider options to regain compliance, including a reverse stock split, if necessary.


auto_awesomeAnalysis

Autonomix Medical, Inc. received a deficiency letter from Nasdaq due to its common stock trading below the minimum $1.00 bid price for 30 consecutive business days. This is a critical event as failure to regain compliance within the 180-day period could lead to delisting from the Nasdaq Capital Market, significantly impacting the company's liquidity and investor confidence. The company is currently trading near its 52-week low, making the challenge to meet the $1.00 threshold more difficult. A reverse stock split is a common, though often dilutive, measure companies take in such situations to boost share price.

この提出時点で、AMIXは$0.46で取引されており、市場はNASDAQ、セクターはIndustrial Applications And Services、時価総額は約$319.9万でした。 52週の取引レンジは$0.46から$3.33でした。 この提出書類はネガティブの市場センチメント、重要度スコア9/10と評価されました。

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed AMIX - Latest Insights

AMIX
Mar 04, 2026, 8:40 AM EST
Source: GlobeNewswire
Importance Score:
7
AMIX
Feb 11, 2026, 5:00 PM EST
Filing Type: 10-Q
Importance Score:
9
AMIX
Jan 16, 2026, 7:30 AM EST
Filing Type: 8-K
Importance Score:
9
AMIX
Jan 09, 2026, 9:11 AM EST
Filing Type: 8-K
Importance Score:
8